Cellular metabolism
AOD9604
Discussed for fat metabolism and body composition (hGH fragment; mixed evidence).
What it is used for
- Body composition / lipolysis (research claims)
- GH fragment 176–191 — without full GH spectrum
- Fat-loss discussions
- “Softer” alternative to full GH in community narrative
Disclaimer — Research Use Only
Materials listed on this website are supplied for laboratory research only (Research Use Only). They are not intended for human consumption.
Quick Facts
- Category
- Cellular metabolism
- Research status
- Early clinical research
- Strength (illustration)
- 10 mg
- Price-list variants
- 5mg · 10mg
- Also known as
- —
Overview
AOD9604 is a growth-hormone fragment studied mainly for lipolysis without the full anabolic GH profile. Clinical results are mixed and limited.
What it is used for
Community and research context — not a medical indication or treatment advice.
- Body composition / lipolysis (research claims)
- GH fragment 176–191 — without full GH spectrum
- Fat-loss discussions
- “Softer” alternative to full GH in community narrative
AOD9604 is a C-terminal growth-hormone fragment discussed for lipolysis and body composition. Marketing can be aggressive (“burns fat without GH sides”); study results are mixed. Do not treat it as a substitute for deficit, cardio or GLP-1.
For people analysing GH fragments and fat-loss claims in research.
How it works
GH region 176–191 was studied for lipid-metabolism effects with limited growth effects versus full GH. Research findings do not imply a consumer or therapeutic product.
The research hypothesis posits effects on lipid metabolism via the C-terminal hGH fragment, without the strong IGF-1 activation typical of full GH.
How it is used (research context)
From protocols and documentation — not a dosing guide.
In research: usually reconstitution + SC use per source documentation. No strong, uniform clinical standard “for everyone”.
Key takeaways
- Use-case: body composition, not a nootropic
- Evidence: mixed — read critically
- Does not replace GLP-1 or diet
- Avoid “no side effects” promises
Who this content is for: For people analysing GH fragments and fat-loss claims in research.
Current research
Early clinical research
Clinical studies of varying quality have been conducted; consensus on efficacy remains cautious.
Contexts from literature — not therapeutic indications.
- Adipose-tissue metabolism
- Body weight (limited data)
- Safety relative to the IGF-1 axis
Potential side effects
- Limited and heterogeneous efficacy data
- Possible injection-site reactions
- No guarantee of a “fat-burning” effect
Frequently asked questions
Does AOD9604 work like growth hormone?
Related scientific papers
Related YouTube videos
YouTube HubNo matching videos — see the YouTube Hub.
Related MarcinLabs articles
ResearchNo direct notes — see the Research Hub.
Related peptides
Semaglutide
Used in research and clinic for body weight, appetite and type 2 diabetes (GLP-1 agonist).
BPC-157
Discussed for tendon, joint and gut healing and soft-tissue recovery (mostly preclinical data).
MOTS-c
Discussed for glucose metabolism, performance and energetic adaptation (mitochondrial peptide).
In the research library
AOD9604